1-4 of 4
Eleni D. Lagadinou, MD
Close
Sort by
Journal Articles

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Kevin P Callahan, PhD, Cheryl Corbett, Steven Jacob, Mohammad Minhajuddin, PhD, Eleni D Lagadinou, MD/PhD, Randall M Rossi, MS, Valerie Gross, Marlene Balys, Fred Hagen, PhD, Alison J Frontier, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2012) 120 (21): 1338.
https://doi.org/10.1182/blood.V120.21.1338.1338
Published: 2012
Journal Articles

Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Eleni D Lagadinou, MD/PhD, Alexander Sach, BS, Kevin P Callahan, PhD, Randall M. Rossi, MS, Sarah Neering, MS, Shanshan Pei, BS, Kristen O'Dwyer, MD, Jane L. Liesveld, MD, Paul S. Brookes, PhD, Michael W. Becker, MD, Craig T. Jordan, PhD
Journal: Blood
Blood (2012) 120 (21): 206.
https://doi.org/10.1182/blood.V120.21.206.206
Published: 2012
Journal Articles

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

Eleni D. Lagadinou, MD, PhD, Dimitra Kokkinou, Elena Siapati, PhD, George Vassilopoulos, MD, PhD, Craig T. Jordan, PhD, Alexandros Spyridonidis, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1580.
https://doi.org/10.1182/blood.V116.21.1580.1580
Published: 2010
Journal Articles

c-Jun N-Terminal Kinase (JNK) Activation Failure Confers a New Mechanism of Anthracycline Resistance in Acute Myeloid Leukemia (AML).

Eleni D. Lagadinou, MD, Panagiotis G. Ziros, PhD, Olga A. Tsopra, MD, Kostas Dimas, PhD, Panagiotis Pantazis, PhD, Alexandros Spyridonidis, MD, PhD, Nicholas C. Zoumbos, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2377.
https://doi.org/10.1182/blood.V110.11.2377.2377
Published: 2007